Prevymis (letermovir) - Merck (MSD)
Letermovir as CMV Prophylaxis in Liver Transplant Recipients (IDWeek 2025) - Sep 3, 2025 - Abstract #88; Pres time: Oct 20, 2025; 11:06 AM - 11:18 AM; Location: B211-B212; No abstract available 
Clinical • Cytomegalovirus Infection • Infectious Disease
https://idweek2025.eventscribe.net/fsPopup.asp?PresentationID=1688545&mode=presInfo
 
Emily A. Siegrist, PharmD; Phu Nguyen, PharmD; Rita Wilson Dib, MD; Joseph Sassine, MD
 
Sep 3, 2025
 
Prev Next